This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Sequelae of poisoning by drugs, medicaments and biological substances
ST19_SEQUEL_POISO_DRUGS_MEDICAM_BIOLO_SUBST
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
66 |
4. Check minimum number of eventsNone |
66 |
5. Include endpointsNone |
66 |
6. Filter based on genotype QC (FinnGen only) |
58 |
Control definitions (FinnGen only)
- Control exclude
- ST19_SEQUEL_INJURI_POISO_OTHER_CONSE_EXTER_CAUSES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T9
- Name in latin
- Sequelae intoxicationum agentibus psychotropicis, medicamentis et substantiis biologicis
Similar endpoints
↥List of similar endpoints to
Sequelae of poisoning by drugs, medicaments and biological substances
based on the number of shared cases.
Similar with more cases:
- Sequelae of injuries, of poisoning and of other consequences of external causes
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 58 | 34 | 24 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 35.19 | 34.69 | 35.91 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 60
- Matched controls
- 600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T96
ICD-10 Finland
Sequelae of poisoning by drugs, medicaments and biological substances
+∞
86.1
60
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
105.9
71.6
43
14
T36
ICD-10 Finland
Poisoning by systemic antibiotics
86.7
67.4
43
17
F32.9
ICD-10 Finland
Depressive episode, unspecified
11.1
20.1
32
56
N05AH04
ATC
quetiapine; oral
10.9
19.7
40
93
XF400
NOMESCO Finland
ECG with 12 standard connections
12.0
19.5
26
36
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
11.9
19.0
25
34
N06AB04
ATC
citalopram; systemic
10.2
18.5
31
57
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
24.4
18.0
26
18
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
10.4
16.7
24
36
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
17.4
15.8
26
25
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
50.1
15.5
18
5
N05BA01
ATC
diazepam; systemic, rectal
8.8
13.7
22
37
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
65.3
13.6
15
*
N05AH03
ATC
olanzapine; systemic
14.2
13.0
23
25
B18.2
ICD-10 Finland
Chronic viral hepatitis C
+∞
13.0
12
*
AA1AD
NOMESCO Finland
CT of head and brain
6.8
12.6
31
81
P19
ICPC
Drug abuse
81.3
12.1
13
*
N06AX11
ATC
mirtazapine; oral
6.0
10.8
39
141
Z72.2
ICD-10 Finland
Drug use
+∞
10.7
10
*
N06AB06
ATC
sertraline; oral
6.3
10.7
25
61
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.8
10.5
21
44
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
25.5
10.4
14
7
N05AX12
ATC
aripiprazole; systemic
11.0
10.2
20
26
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
66.1
10.0
11
*
N05AA02
ATC
levomepromazine; systemic
17.7
9.8
15
11
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
+∞
9.6
9
*
N05BA04
ATC
oxazepam; oral
5.0
8.9
32
111
P15
ICPC
Chronic alcohol abuse
24.5
8.9
12
6
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
104.1
8.7
9
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
104.1
8.7
9
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
+∞
8.5
8
*
X58
ICD-10 Finland
Exposure to other specified factors
5.4
8.4
22
58
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
39.2
8.4
10
*
N05CF01
ATC
zopiclone; oral
4.7
8.2
32
117
N03AX09
ATC
lamotrigine; oral
10.0
8.0
16
21
N07BB01
ATC
disulfiram; oral
13.4
7.7
13
12
N05BA12
ATC
alprazolam; oral
8.3
7.6
17
27
R40.2
ICD-10 Finland
Coma, unspecified
+∞
7.4
7
*
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
+∞
7.4
7
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
+∞
7.4
7
*
P18
ICPC
Medication abuse
34.6
7.4
9
*
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
34.6
7.4
9
*
N03AG01
ATC
valproic acid; systemic, rectal
9.1
7.3
15
21
P01AB01
ATC
metronidazole; oral, rectal
4.3
7.3
33
133
F29
ICD-10 Finland
Unspecified nonorganic psychosis
8.7
7.1
15
22
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
26.0
6.9
9
*
P03
ICPC
Feeling depressed
4.6
6.8
21
63
TKC20
NOMESCO Finland
Catheterisation of bladder
10.0
6.8
13
16
N05AX08
ATC
risperidone; systemic
7.4
6.7
16
28
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.9
6.7
18
48
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
6.6
36
162
F10.09
ICD-10 Finland
Alcohol intoxication UNS
77.8
6.6
7
*
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
77.8
6.6
7
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
77.8
6.6
7
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
77.8
6.6
7
*
P01
ICPC
Feeling anxious/nervous/tense
4.1
6.6
27
100
N06AX16
ATC
venlafaxine; oral
4.4
6.5
21
65
N03AE01
ATC
clonazepam; systemic
10.4
6.4
12
14
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
+∞
6.4
6
*
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
+∞
6.4
6
*
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
+∞
6.4
6
*
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
+∞
6.4
6
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.9
6.3
28
109
TPH04
NOMESCO Finland
Cathetrisation of vein
4.2
6.1
21
68
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
13.0
6.0
10
9
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
23
49
6.99
11.37
4.4
12.5
104.30
104.24
mmol/l
0.02
23
49
19
41
6.32
9.10
1.8
1.4
0.30
0.21
mg/l
0.29
14
15
17
29
7.74
7.30
3.5
17.0
1.65
1.02
mmol/l
1.41
17
29
17
49
4.45
5.67
2.5
1.3
—
—
—
0
0
14
27
6.43
5.51
3.4
18.5
0.62
0.65
%
0.09
14
27
13
23
6.90
5.44
2.8
1.9
24.20
24.42
mmol/l
0.12
13
23
11
15
8.70
5.42
3.1
2.5
0.56
0.64
%
0.44
11
15
14
29
5.96
5.22
3.4
17.5
3.44
1.32
%
2.67
14
29
9
10
10.33
4.98
11.6
9.5
644.56
809.20
nmol/l
—
9
10
20
72
3.67
4.87
2.5
1.5
—
—
—
0
0
9
11
9.38
4.75
15.4
10.3
1391.89
1467.36
nmol/l
—
9
11
34
181
3.03
4.26
5.3
5.5
34.74
36.87
g/l
1.19
29
176
36
199
3.02
4.19
1.8
1.9
104.94
96.30
pmol/l
0.31
18
115
12
28
5.09
4.09
3.8
18.1
90.77
94.57
%
1.42
12
28
14
45
3.75
3.95
7.5
2.6
229.38
11044.68
u/l
—
5
19
14
48
3.50
3.58
2.9
1.3
—
—
—
0
0
18
73
3.09
3.54
2.1
1.7
409.44
465.69
pmol/l
0.46
18
67
6
7
9.35
3.34
1.7
1.3
—
—
—
0
0
9
24
4.22
2.80
3.1
19.8
22.89
24.37
mmol/l
—
9
24
5
6
8.94
2.80
1.4
1.2
—
—
—
0
0
5
6
8.94
2.80
1.8
1.3
—
—
—
0
0
9
25
4.05
2.70
4.8
12.8
24.33
24.42
mmol/l
—
9
25
8
22
4.03
2.46
1.3
1.2
—
—
—
0
0
12
49
2.81
2.27
3.2
4.0
34.57
32.69
%
—
7
35
25
147
2.20
2.20
2.8
2.3
—
—
—
0
0
25
150
2.14
2.08
8.5
2.9
11.83
39.51
ng/l
0.98
18
87
14
67
2.42
1.95
1.7
1.6
1125.33
1255.69
nmol/l
—
9
54
5
12
4.44
1.86
10.8
1.0
—
—
—
0
0
38
275
2.04
1.85
6.5
3.2
0.00
0.00
estimate
—
5
53
25
157
2.02
1.80
3.0
2.5
—
—
—
0
0
7
24
3.16
1.78
1.6
1.3
—
—
—
0
0
21
126
2.03
1.69
5.8
2.9
1.02
1.02
kg/l
0.48
16
81
20
119
2.02
1.64
1.8
1.9
0.69
0.87
mg/l
0.30
15
85
7
26
2.91
1.63
1.0
1.7
—
—
—
0
0
11
53
2.32
1.49
1.9
3.1
21.45
30.49
u/l
1.16
11
43
36
269
1.85
1.46
5.1
3.2
0.00
0.00
estimate
—
5
58
9
41
2.40
1.44
15.0
3.2
—
—
—
0
0
11
54
2.27
1.43
2.3
1.9
351.91
424.29
nmol/l
0.52
11
48
36
273
1.80
1.35
6.5
3.2
0.00
27.53
estimate
—
5
59
13
71
2.06
1.32
5.7
2.0
—
—
—
0
0
32
239
1.73
1.23
2.2
3.0
—
—
estimate
—
0
0
5
20
2.63
1.17
1.0
1.3
—
—
—
0
0
21
146
1.67
1.01
7.2
3.2
0.00
0.00
estimate
—
5
58
0
31
0.00
0.99
0.0
1.5
—
—
—
0
0
8
48
1.77
0.82
8.0
4.8
—
—
—
0
0
5
28
1.86
0.68
1.0
1.4
6.18
3.86
mg/l
—
5
19
13
89
1.59
0.64
6.5
2.2
—
—
—
0
0
24
200
1.33
0.43
1.9
1.7
1.26
1.36
mmol/l
0.29
16
181
5
35
1.47
0.40
1.8
1.3
—
—
—
0
0
20
164
1.33
0.40
5.3
3.1
—
—
—
0
0
8
109
0.69
0.32
1.9
2.9
331.63
333.73
umol/l
—
8
103
46
432
1.28
0.27
3.5
3.9
—
—
—
0
0
8
104
0.73
0.23
1.6
1.3
—
12.23
—
0
33
14
117
1.26
0.23
1.9
2.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
53.82
—
0
11
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.7
—
7.12
—
0
13
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
18
159
1.19
0.18
2.0
1.4
2.55
1.88
u/ml
—
8
39
48
497
0.83
0.15
5.4
4.3
2.65
2.74
mmol/l
0.28
43
476
49
473
1.20
0.14
34.5
16.3
332.98
334.11
g/l
0.30
49
473
15
164
0.89
0.09
1.6
1.8
—
—
—
0
0
7
80
0.86
0.07
3.0
2.7
2.40
2.40
mmol/l
—
7
72
11
112
0.98
0.00
2.2
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.29
—
0
5
0
7
0.00
-0.00
0.0
6.7
—
147.81
—
0
7
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_SEQUEL_POISO_DRUGS_MEDICAM_BIOLO_SUBST – Sequelae of poisoning by drugs, medicaments and biological substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).